IHC4 score10 and PREDICT11 are immunohistochemistry‐based tests that use the expression of breast cancer biomarkers‐estrogen receptor (ER), progesterone receptor (PR), Ki‐67, and HER2/neu for prognostication. Here, ERBB2 is linked to breast cancer.